MedTrace Logo

Mucosal Immunity of Ulcerative Colitis Patients Undergoing Therapy With Trichuris Suis Ova

NCT01433471 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2016-07-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to understand the immune response activated in the human gastrointestinal tract by Trichuris Suis Ova (TSO) in patients with ulcerative colitis.

Conditions

Interventions

DRUG

Trichuris suis ova

2,500 eggs by mouth every two weeks for 12 weeks

Sponsors & Collaborators

Principal Investigators

  • Michael A Poles, M.D., Ph.D. · NYU Langone Health

  • P'ng Loke, Ph.D. · NYU Langone Health

  • Martin J Wolff, M.D. · NYU Langone Health

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
72 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01433471 on ClinicalTrials.gov